The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovative, multidisciplinary intervention that has the potential to transform the standard of care for patients receiving surgical treatment for lung cancer.
> 21 years of age English speaking MD approval to participate in study Meets one of the inclusions below: 1. a histological diagnosis of NSCLC undergoing potentially curative treatment 2. OR those undergoing surgical procedures for lung cancer (includes patients undergoing diagnostic testing or those presenting with lung nodules 3.OR patients who have had a surgical procedure for lung cancer within the last six months. May invite a buddy to join study with them defined as a friend, partner, adult child or sibling
Buddy Inclusion Criteria:
≥ 21 years of age, English speaking, who is invited by the subject to join as a support person (e.g., friend, partner, adult child or sibling)
